Preliminary results of a Phase II study to evaluate gefitinib combined with docetaxel and cisplatin in patients with recurrent and/or metastatic squamous-cell carcinoma of the head and neck. - Belón,J.; Irigoyen,A.; Rodríguez,I.; Escobar,Y.; Alonso,J.; Pastor,P.; Valdivia,J.; Concha,A.; Nuevo,J.; Bovio,H. (J Clin Oncol, 2005)